Clinical Trial Applications - Rejected: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Rejected | |
|---|---|---|---|---|---|
1. |
ECCT/21/11/03 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older |
Principal Investigator(s) 1. Paul Otieno Yonga Site(s) in Kenya 1. Fountain Projects and Research Office Clinical Research Centre (FOPRO-CRC), Fountain Health Care Hospital (Uasin Gishu county) 2. Moi University Clinical Research Centre (Uasin Gishu county) 3. KEMRI/Walter Reed Project Research Centre (Kericho county) 4. KEMRI-UAMRD-A/K, Kombewa Clinical Research Centre (Kisumu county) 5. Ganjoni Clinic (Mombasa county) 6. KAVI-Institute of Clinical Research, University of Nairobi (Nairobi City county) 7. KEMRI/CCR Partners in Health R & D (PHRD) (Nairobi City county) 8. KEMRI-CDC CRC (Kisumu county) 9. Aga Khan University Hospital (Nairobi City county) 10. KEMRI CCR (Kakamega county) |
13-02-2022 |
View |